Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.16)
# 1,418
Out of 4,479 analysts
294
Total ratings
36.73%
Success rate
3.15%
Average return
Main Sectors:
55 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals | Reiterates: Buy | $5 | $0.54 | +818.61% | 10 | Jun 28, 2024 | |
| INAB IN8bio | Reiterates: Buy | $13 | $0.81 | +1,446.46% | 11 | Jun 14, 2024 | |
| AFMD Affimed | Reiterates: Buy | $10 | $5.16 | +93.99% | 9 | Jun 13, 2024 | |
| IPHA Innate Pharma | Reiterates: Buy | $12 | $2.06 | +458.25% | 8 | Jun 12, 2024 | |
| ALXO ALX Oncology Holdings | Reiterates: Buy | $25 | $5.72 | +337.06% | 9 | Jun 10, 2024 | |
| EVAX Evaxion Biotech | Reiterates: Buy | $14 | $2.90 | +383.59% | 4 | Jun 4, 2024 | |
| PGEN Precigen | Reiterates: Buy | $6 | $1.49 | +302.68% | 6 | Jun 3, 2024 | |
| CYTH Cyclo Therapeutics | Reiterates: Buy | $3 | $1.21 | +147.93% | 2 | May 31, 2024 | |
| CLGN CollPlant Biotechnologies | Reiterates: Buy | $11 | $4.96 | +121.77% | 7 | May 30, 2024 | |
| MDWD MediWound | Reiterates: Buy | $28 | $15.56 | +79.95% | 11 | May 30, 2024 | |
| CORT Corcept Therapeutics | Reiterates: Buy | $40 | $31.56 | +26.74% | 12 | May 29, 2024 | |
| EDAP EDAP TMS | Reiterates: Buy | $19 | $5.30 | +258.49% | 10 | May 17, 2024 | |
| CELC Celcuity | Reiterates: Buy | $27 | $16.19 | +66.77% | 3 | May 16, 2024 | |
| ASXC Asensus Surgical | Reiterates: Neutral | $0.35 | $0.33 | +5.58% | 11 | May 16, 2024 | |
| LFWD ReWalk Robotics | Maintains: Buy | $9 → $13 | $3.64 | +257.14% | 3 | May 16, 2024 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $7 | $2.94 | +138.10% | 4 | May 16, 2024 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $40 | $26.27 | +52.26% | 1 | May 16, 2024 | |
| DCTH Delcath Systems | Maintains: Buy | $20 → $22 | $7.91 | +178.13% | 7 | May 15, 2024 | |
| ABSI Absci | Reiterates: Buy | $7 | $2.97 | +135.69% | 7 | May 15, 2024 | |
| OCGN Ocugen | Reiterates: Buy | $7 | $1.61 | +334.78% | 14 | May 15, 2024 | |
| LPTX Leap Therapeutics | Maintains: Buy | $7 → $5.5 | $1.69 | +225.44% | 7 | May 14, 2024 | |
| JANX Janux Therapeutics | Maintains: Buy | $50 → $63 | $39.30 | +60.31% | 8 | May 13, 2024 | |
| ITOS iTeos Therapeutics | Maintains: Buy | $44 → $46 | $14.44 | +218.56% | 6 | May 13, 2024 | |
| QSI Quantum-Si incorporated | Reiterates: Buy | $4 | $0.95 | +320.12% | 3 | May 10, 2024 | |
| VCEL Vericel | Maintains: Buy | $53 → $55 | $45.07 | +22.03% | 11 | May 9, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $55 | $19.81 | +177.64% | 9 | May 3, 2024 | |
| MDXG MiMedx Group | Reiterates: Buy | $11 | $6.78 | +62.24% | 8 | May 1, 2024 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $9.25 → $10 | $1.03 | +870.87% | 6 | Apr 30, 2024 | |
| ELEV Elevation Oncology | Reiterates: Buy | $6 | $2.80 | +114.29% | 4 | Apr 9, 2024 | |
| CALC CalciMedica | Reiterates: Buy | $20 | $4.01 | +398.75% | 1 | Apr 1, 2024 | |
| AVGR Avinger | Reiterates: Buy | $5 | $1.79 | +179.33% | 5 | Mar 21, 2024 | |
| VOR Vor Biopharma | Reiterates: Buy | $18 | $0.91 | +1,814.66% | 7 | Mar 21, 2024 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Buy | $9 | $1.04 | +769.57% | 5 | Mar 15, 2024 | |
| ECOR electroCore | Reiterates: Buy | $15 | $6.32 | +137.34% | 10 | Mar 14, 2024 | |
| SLDB Solid Biosciences | Initiates: Buy | $9 | $5.96 | +51.01% | 1 | Dec 8, 2023 | |
| TCRT Alaunos Therapeutics | Downgrades: Neutral | n/a | $0.63 | - | 2 | Aug 16, 2023 | |
| PSNL Personalis | Maintains: Buy | $10 → $7.5 | $1.20 | +525.00% | 9 | Aug 9, 2023 | |
| CDXS Codexis | Downgrades: Neutral | n/a | $2.89 | - | 10 | May 9, 2023 | |
| LVTX LAVA Therapeutics | Reiterates: Buy | $9 | $1.87 | +381.28% | 1 | Feb 17, 2023 | |
| CELU Celularity | Maintains: Buy | $150 → $25 | $3.11 | +705.15% | 2 | Jan 30, 2023 | |
| PSTX Poseida Therapeutics | Initiates: Buy | $15 | $3.02 | +396.69% | 1 | Jan 4, 2023 | |
| ADAG Adagene | Initiates: Buy | $5 | $2.99 | +67.22% | 1 | Dec 7, 2022 | |
| CLRB Cellectar Biosciences | Maintains: Buy | $3 → $4 | $2.38 | +68.07% | 1 | Nov 4, 2022 | |
| CALA Calithera Biosciences | Upgrades: Buy | $8 | $0.01 | +63,900.00% | 2 | Aug 29, 2022 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $3 → $12 | $5.41 | +121.81% | 2 | Aug 15, 2022 | |
| BCAB BioAtla | Maintains: Buy | $25 → $20 | $1.32 | +1,415.15% | 2 | Aug 10, 2022 | |
| PLSE Pulse Biosciences | Downgrades: Neutral | n/a | $11.41 | - | 5 | May 13, 2022 | |
| HOOK HOOKIPA Pharma | Maintains: Buy | $15 → $8 | $0.58 | +1,275.52% | 4 | Feb 17, 2022 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | n/a | $1.78 | - | 3 | Jul 16, 2021 | |
| INMB INmune Bio | Maintains: Buy | n/a | $8.07 | - | 2 | Jul 15, 2020 | |
| IGXT IntelGenx Technologies | Reiterates: Buy | n/a | $0.17 | - | 1 | Mar 30, 2020 | |
| VSTM Verastem | Maintains: Buy | n/a | $2.94 | - | 1 | Mar 16, 2020 | |
| ATEC Alphatec Holdings | Reiterates: Buy | n/a | $9.90 | - | 2 | Mar 6, 2020 | |
| RDHL RedHill Biopharma | Reiterates: Buy | n/a | $0.36 | - | 1 | Mar 5, 2020 | |
| ADXS Ayala Pharmaceuticals | Downgrades: Neutral | n/a | $0.28 | - | 2 | Dec 18, 2018 |
X4 Pharmaceuticals
Jun 28, 2024
Reiterates: Buy
Price Target: $5
Current: $0.54
Upside: +818.61%
IN8bio
Jun 14, 2024
Reiterates: Buy
Price Target: $13
Current: $0.81
Upside: +1,446.46%
Affimed
Jun 13, 2024
Reiterates: Buy
Price Target: $10
Current: $5.16
Upside: +93.99%
Innate Pharma
Jun 12, 2024
Reiterates: Buy
Price Target: $12
Current: $2.06
Upside: +458.25%
ALX Oncology Holdings
Jun 10, 2024
Reiterates: Buy
Price Target: $25
Current: $5.72
Upside: +337.06%
Evaxion Biotech
Jun 4, 2024
Reiterates: Buy
Price Target: $14
Current: $2.90
Upside: +383.59%
Precigen
Jun 3, 2024
Reiterates: Buy
Price Target: $6
Current: $1.49
Upside: +302.68%
Cyclo Therapeutics
May 31, 2024
Reiterates: Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
CollPlant Biotechnologies
May 30, 2024
Reiterates: Buy
Price Target: $11
Current: $4.96
Upside: +121.77%
MediWound
May 30, 2024
Reiterates: Buy
Price Target: $28
Current: $15.56
Upside: +79.95%
Corcept Therapeutics
May 29, 2024
Reiterates: Buy
Price Target: $40
Current: $31.56
Upside: +26.74%
EDAP TMS
May 17, 2024
Reiterates: Buy
Price Target: $19
Current: $5.30
Upside: +258.49%
Celcuity
May 16, 2024
Reiterates: Buy
Price Target: $27
Current: $16.19
Upside: +66.77%
Asensus Surgical
May 16, 2024
Reiterates: Neutral
Price Target: $0.35
Current: $0.33
Upside: +5.58%
ReWalk Robotics
May 16, 2024
Maintains: Buy
Price Target: $9 → $13
Current: $3.64
Upside: +257.14%
Pyxis Oncology
May 16, 2024
Reiterates: Buy
Price Target: $7
Current: $2.94
Upside: +138.10%
Dianthus Therapeutics
May 16, 2024
Initiates: Buy
Price Target: $40
Current: $26.27
Upside: +52.26%
Delcath Systems
May 15, 2024
Maintains: Buy
Price Target: $20 → $22
Current: $7.91
Upside: +178.13%
Absci
May 15, 2024
Reiterates: Buy
Price Target: $7
Current: $2.97
Upside: +135.69%
Ocugen
May 15, 2024
Reiterates: Buy
Price Target: $7
Current: $1.61
Upside: +334.78%
Leap Therapeutics
May 14, 2024
Maintains: Buy
Price Target: $7 → $5.5
Current: $1.69
Upside: +225.44%
Janux Therapeutics
May 13, 2024
Maintains: Buy
Price Target: $50 → $63
Current: $39.30
Upside: +60.31%
iTeos Therapeutics
May 13, 2024
Maintains: Buy
Price Target: $44 → $46
Current: $14.44
Upside: +218.56%
Quantum-Si incorporated
May 10, 2024
Reiterates: Buy
Price Target: $4
Current: $0.95
Upside: +320.12%
Vericel
May 9, 2024
Maintains: Buy
Price Target: $53 → $55
Current: $45.07
Upside: +22.03%
Bicycle Therapeutics
May 3, 2024
Reiterates: Buy
Price Target: $55
Current: $19.81
Upside: +177.64%
MiMedx Group
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $6.78
Upside: +62.24%
Ekso Bionics Holdings
Apr 30, 2024
Maintains: Buy
Price Target: $9.25 → $10
Current: $1.03
Upside: +870.87%
Elevation Oncology
Apr 9, 2024
Reiterates: Buy
Price Target: $6
Current: $2.80
Upside: +114.29%
CalciMedica
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $4.01
Upside: +398.75%
Avinger
Mar 21, 2024
Reiterates: Buy
Price Target: $5
Current: $1.79
Upside: +179.33%
Vor Biopharma
Mar 21, 2024
Reiterates: Buy
Price Target: $18
Current: $0.91
Upside: +1,814.66%
ImmunoPrecise Antibodies
Mar 15, 2024
Reiterates: Buy
Price Target: $9
Current: $1.04
Upside: +769.57%
electroCore
Mar 14, 2024
Reiterates: Buy
Price Target: $15
Current: $6.32
Upside: +137.34%
Solid Biosciences
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.96
Upside: +51.01%
Alaunos Therapeutics
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.63
Upside: -
Personalis
Aug 9, 2023
Maintains: Buy
Price Target: $10 → $7.5
Current: $1.20
Upside: +525.00%
Codexis
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.89
Upside: -
LAVA Therapeutics
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.87
Upside: +381.28%
Celularity
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $3.11
Upside: +705.15%
Poseida Therapeutics
Jan 4, 2023
Initiates: Buy
Price Target: $15
Current: $3.02
Upside: +396.69%
Adagene
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.99
Upside: +67.22%
Cellectar Biosciences
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $2.38
Upside: +68.07%
Calithera Biosciences
Aug 29, 2022
Upgrades: Buy
Price Target: $8
Current: $0.01
Upside: +63,900.00%
CASI Pharmaceuticals
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $5.41
Upside: +121.81%
BioAtla
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $1.32
Upside: +1,415.15%
Pulse Biosciences
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $11.41
Upside: -
HOOKIPA Pharma
Feb 17, 2022
Maintains: Buy
Price Target: $15 → $8
Current: $0.58
Upside: +1,275.52%
Corvus Pharmaceuticals
Jul 16, 2021
Maintains: Buy
Price Target: n/a
Current: $1.78
Upside: -
INmune Bio
Jul 15, 2020
Maintains: Buy
Price Target: n/a
Current: $8.07
Upside: -
IntelGenx Technologies
Mar 30, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.17
Upside: -
Verastem
Mar 16, 2020
Maintains: Buy
Price Target: n/a
Current: $2.94
Upside: -
Alphatec Holdings
Mar 6, 2020
Reiterates: Buy
Price Target: n/a
Current: $9.90
Upside: -
RedHill Biopharma
Mar 5, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.36
Upside: -
Ayala Pharmaceuticals
Dec 18, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.28
Upside: -